Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 151 - 160 of 210 for 3SBio. (0.11 seconds)

For the first time in 29 years, the industry's most...
Simcere Pharma has filed an Investigational New Drug...
It's earnings season, and almost every day for the past...
Epitomics, the San Francisco-area biopharma with two...
Simcere Pharma was given SFDA approval to begin China...
PW Medtech Group of China paid $130 million to acquire...
GlaxoSmithKline will pay a $489 million fine to settle...
Innovent Biologics of Suzhou expanded its 10-year...
Hutchison China MediTech (Chi-Med) will raise $100...
Sorrento Therapeutics, a San Diego-China biopharma,...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here